AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05763212 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Reverse Walking+Baseline treatment
Description: Reverse Walking+Baseline treatment
Study NCT05763212 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration + Reverse Walking+Baseline treatment
Description: Whole Body Vibration + Reverse Walking+Baseline treatment
Study NCT04718961 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Volixibat
Description: Oral capsules, administered twice daily. Volixibat is an ileal bile acid transporter (IBAT) inhibitor.
Study NCT04718961 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsules matched to study drug minus active substance.
Study NCT04722809 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: visual analogue pain scale
Description: Evaluation of jaw pain. At inclusion and 3 months post-injection
Study NCT04722809 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Endobuccal and linea alba photographs
Description: anonymous endobuccal and linea alba photographs (line on the inner face of the cheeks as the result of chronic friction).~At inclusion
Study NCT06569589 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 23NaMRI Scan
Description: 23NaMRI, a non-invasive detection and quantification of hidden tissue Na+ stores in humans.
Study NCT05137704 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: This is a non-interventional study.
Study NCT05708820 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online education programme
Description: Online group will follow the education programme through videos that they can view at any time and a live session to answer questions.
Study NCT06556472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Terlipressin
Description: 1. Patients in this group will receive continuous terlipressin infusion (1 mg/24 hr on day 1, increasing to 1 mg in 24 hours if target MAP not achieved ,reaching maximum terlipressin dose of 4 mg/24 hr on day 4).If target MAP not achieved by terlipressin dose ,increase noradrenaline dose keeping terlipressin maximum 1 mg ,2 mg ,3mg ,4mg at Day 1,2,3,4 respectively.
Study NCT06556472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Norephrine
Description: 1. Patients in this group will receive norepinephrine only, with a dose range of 0.05 mcg/kg/min to 0.5 mcg/kg/min to maintain a MAP > 65 to 75 mm Hg.
Study NCT06556472 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Norephrine
Description: 1. Patients in this group will receive norepinephrine only, with a dose range of 0.05 mcg/kg/min to 0.5 mcg/kg/min to maintain a MAP > 65 to 75 mm Hg.
Study NCT06353750 — intervention group
Intervention type: OTHER
Intervention: Magnesium supplement
Description: Intravenous magnesium supplement (10mmol).
Study NCT05557656 — intervention group
Intervention type: DRUG
Intervention: Regorafenib 40 MG
Description: participants who received the treatment of Regorafenib
Study NCT05708820 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard education programme
Description: Face-to-face educacion programme in a group session
Study NCT06285006 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Desmopressin
Description: Desmopressin is a synthetic analogue of ADH released by the posterior pituitary gland that reduces urine production by increasing water reabsorption by the collecting tubules.
Study NCT05316389 — intervention group
Intervention type: PROCEDURE
Intervention: Breast reconstruction
Description: Muscle sparing Latissimus Dorsi Flap or prothesis
Study NCT04980456 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Lehfilcon A contact lenses
Description: Investigational silicone hydrogel contact lenses
Study NCT04980456 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Comfilcon A contact lenses
Description: Commercially available silicone hydrogel contact lenses
Study NCT04980456 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: CLEAR CARE
Description: Hydrogen peroxide-based cleaning and disinfecting solution
Study NCT06449417 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental Aurora Training
Description: Patients will be asked to record their physical activity in the logbook every week, at the end of the intervention, each patient will have to dedicate a letter to another patient who will receive the same Aurora Kit.
Study NCT06246058 — intervention group
Intervention type: BEHAVIORAL
Intervention: Partner support
Description: The intervention group's survey vignette will include a component of partner support which serves as the key behavioral manipulation tested for this study's primary outcome.
Study NCT06246058 — intervention group
Intervention type: BEHAVIORAL
Intervention: Formal recruiter attire
Description: The SWAT will separately test recruitment rates - as measured by rate of survey completion divided by total number of individuals approached - based on how the recruiters are dressed.~FORMAL dress code of the recruiter is the intervention in this case, defined as clinical attire alluding to some clinical authority.
Study NCT06246058 — intervention group
Intervention type: BEHAVIORAL
Intervention: Without Partner support
Description: The intervention group's survey vignette will NOT include a component of partner support which serves as the key behavioral manipulation tested for this study's primary outcome.
Study NCT06246058 — intervention group
Intervention type: BEHAVIORAL
Intervention: Casual recruiter attire
Description: The SWAT will separately test recruitment rates - as measured by rate of survey completion divided by total number of individuals approached - based on how the recruiters are dressed.~CASUAL dress code of the recruiter is the intervention in this case.
Study NCT06544122 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial direct current stimulation
Description: Anodal tDCS will be applied at an intensity of 2mA and duration of 20 minutes. The assembly of the electrodes during the tDCS sessions will be carried out as follows: primary motor cortex, the stimulation electrode (anode) will be positioned on C5 (international EEG 10-20 system), in S1 (2cm posterior to C5), at the PFCDL (Fp3), all with the cathode positioned on the region contralateral supraorbital. For cerebellar tDCS the anode will be positioned on the inion area and the cathode on the deltoide muscle.
Study NCT05247398 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dynamic Stability Exercise Program
Description: The thumb CMC DS intervention involves four 60-minute occupational therapy visits as well as a daily home program across a 8-week period. Clinic visits focus primarily on home program coaching, and progression of the exercise regimen. Home programs involve daily exercises which follow the intensity and duration recommended for older adults.
Study NCT05878431 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foot Reflexology
Description: The patients in the experimental group underwent 12 sessions of foot reflexology in a quiet room, twice a week, for 6 weeks. No application was made to the patients in the control group.~FOOT REFLEXOLOGY APPLICATION STAGES~* Application of heating methods such as Achilles tendon stretching, wrist loosening, walking the thumbs of both hands on the soles of the feet and wringing the laundry, which lasts about 3 minutes,~* Pressure on the brain, cervical region, solar plexus (the projection of the central nervous system on the sole of the foot), lymph system, adrenal glands, urinary system, digestive system, sciatic nerve, hips, knees and reflex points on the soles of the legs for about 10-15 minutes. implementation (Figure 3.4),~* Ending the application by applying heating methods such as Achilles tendon stretching, wrist loosening, walking the thumbs of both hands on the soles of the feet and wringing the laundry, which lasts approximately 3 minutes after the application.
Study NCT04802213 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation exercise
Description: Rehabilitation exercise use the methods that suggested by previous studies including finger wall climbing, pendulum exercise, and arms lifting.
Study NCT04802213 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation exercise
Description: Rehabilitation exercise use the methods that suggested by previous studies including finger wall climbing, pendulum exercise, and arms lifting.
Study NCT04802213 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: joint mobilization device treatment
Description: The joint mobilization treatment used the mobilization device that developed in this research.It is a device developed by using the design of the vibration force generated by the vibration mechanism and the technologies to simulate the mobilization of the shoulder joint.When the subject uses the device, first sit on a seat that can be adjusted according to the user's body shape and buckle the shoulder fixation device. Then use the specially designed shoulder movement setting mechanism of the device to set the user's shoulder movement and movement angle.The next step is to set the direction and magnitude of the vibration force applied by the device to the shoulder joint in accordance with the joint mobilization technique (posterior, anterior, and inferior) that the therapist or user intends to perform to achieve the effect of simulating joint mobilization and increasing joint mobility.
Study NCT04802213 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: laser acupuncture device treatment
Description: The laser acupuncture treatment use the laser acupuncture device that developed in this research. A gallium-aluminium-arsenide (GaAlAs, infrared laser) continuous wave diode laser device with a wavelength of 850nm (invisible), a power output of 100 mW, and a spot area of 0.07cm2 was used for laser acupuncture.When performing laser acupuncture treatment, the laser emitted by the device is irradiated on the selected acupuncture points .The acupuncture points (GB 21, LI 4, LI 11, LI 14, LI15, LI 16, SI 9, SI 10, SI 11, TE 14, and TE 15) were determined according to the literature regarding acupuncture application in shoulder pain based on traditional chinese acupuncture.
Study NCT05273736 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 5 Behavioral Change Techniques
Description: 1. Goal setting: set or agree on a goal defined in terms of behavior to be achieved. Example: Set the goal to take your medication as prescribed tomorrow.~2. Action planning: prompt detailed planning of performance of behavior (must include a setting, frequency, duration, and intensity). Example: Develop a plan for taking your medication.~3. Self-Monitoring of behavior: establish a method for person to monitor and record their behavior. Example: Did you take your statin medication today?~4. Feedback on behavior: Monitor and provide informative or evaluative feedback on performance of the behavior (e.g. form, frequency, duration, intensity). Example: You did not take your statin medication as prescribed yesterday.~5. Prompts/Cues: introduce or define environmental or social stimulus with the purpose of prompting or cueing the behavior. The prompt or cue would normally occur at the time or place of performance. Example: Please remember to take your medication soon.
Study NCT05305573 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: COVID-19 Vaccine HIPRA 40 ug/dose
Description: Subjects will receive one injection of COVID-19 Vaccine HIPRA (PHH-1V)
Study NCT05305573 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Comirnaty (Pfizer-BioNtech) 30 ug/dose concentrate for dispersion for injection
Description: Subjects will receive one injection of Comirnaty Vaccine
Study NCT06238973 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group Low
Description: In order to maintain arterial blood pressure within the range of 50-57 mmHg, Sevoflurane at a concentration of 0.5-1 MAC and Remifentanil at a rate of 0.05-0.3 mcg/kg/min will be used. If additional hypotensive agents are required, an infusion of Esmolol at a rate of 25-200 mcg/kg/min will be initiated.
Study NCT06238973 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group Middle
Description: In order to maintain arterial blood pressure within the range of 58-65 mmHg, Sevoflurane at a concentration of 0.5-1 MAC and Remifentanil at a rate of 0.05-0.3 mcg/kg/min will be used. If additional hypotensive agents are required, an infusion of Esmolol at a rate of 25-200 mcg/kg/min will be initiated.
Study NCT04612075 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: FDG-PET/MRI
Description: Performed at baseline, interim and at 12-16 weeks post radiotherapy.
Study NCT06323083 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Emotional Freedom Technique
Description: Emotional freedom techniques is a psychophysiological intervention that combines psychological methods from traditional therapies with somatic stimulation. EFT involves tapping acupuncture points to desensitize negative emotions by focusing on the emotion.
Study NCT05737628 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BYON4228 + Rituximab
Description: 20 mg/mL BYON4228 in 8 mL solution for infusion.~Rituximab 500 mg concentrate for solution for infusion.
Study NCT05879666 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online educational phthalate course
Description: This is an online course focused on phthalates for reproductive health professionals. It consists of videos from patient, scientist, and OBGYN perspectives describing how phthalates relate to reproductive health. There is also an interactive module and worksheet to facilitate conversations about phthalates with pregnant individuals.
Study NCT05343884 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Myocardial perfusion imaging
Description: Myocardial perfusion imaging
Study NCT06504875 — intervention group
Intervention type: DRUG
Intervention: Tislelizumab
Description: Tislelizumab 200mg ivd D1
Study NCT06504875 — intervention group
Intervention type: DRUG
Intervention: Interleukin-2
Description: Interleukin 2 100IU HD,QOD d1-d14
Study NCT06504875 — intervention group
Intervention type: DRUG
Intervention: Capecitabine
Description: Capecitabine: 1000mg/m2 bid po, d1-d14
Study NCT06504875 — intervention group
Intervention type: DRUG
Intervention: Oxaliplatin
Description: Oxaliplatin 130mg/m2 ivd, d1
Study NCT05634213 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: normal saline
Description: Once the patient is placed on cardiopulmonary bypass, the product will be injected into the left atrial wall using a 27 gauge needle as 4 injections of 200 μL each. Two will be placed in the atrial appendage. The remaining 2 injections will be placed equidistant on the anterior atrial free wall. Each injection will be performed just under the surface of the atrial epicardium over 30 seconds. The needle will stay in place for 10 seconds after the injection to limit back flow from the site of injection.
Study NCT06098027 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C]CS0159
Description: Single oral administration of 4mg \[14C\]CS0159
Study NCT04248764 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foam roller application
Description: Following the fatigue protocol, foam roller application will be applied to the quadriceps femoris muscle for five minutes in the prone position.
Study NCT04248764 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Massage application
Description: Following the fatigue protocol, sports massage will be applied to the quadriceps femoris muscle for five minutes.
Study NCT05005637 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti Tuberculosis Drug
Description: ATT will be given in the form of fixed drug combination (FDC). Each patient will get a regimen of 2RHZE (2 months of FDC intensive phase, which contains of Rifampicin, Isoniazide, Pirazinamide, Ethambutol) + 4RH (4 months of FDC continuation phase, which contains of Rifampicin and Isoniazid). The dosage will be according to body weight, 30-37 kg: 2 tablets, 38-54 kg: 3 tablets, 55-70 kg: 4 tablets, more than 70 kg: 5 tablets. FDC drugs have to be consumed daily during intensive phase and three times a week during continuation phase.
Study NCT05005637 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisone tablet
Description: Oral prednisone will be given at the dose of 1 mg/kgBW/day (max 60 mg/day) until the uveitis is controlled or up to 4 weeks of administration, after that the dose will be tappered off gradually.
Study NCT05878041 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Molecular and genetic screening
Description: Molecular and genetic screening
Study NCT06334562 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SUGAMMADEX SODIUM 100 Mg in 1 mL
Description: The dose of Sugammadex Sodium 100 Mg in 1 mL is 2mg/kg
Study NCT06334562 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neostigmine
Description: Neostigmine is 50 μg/kg
Study NCT06381687 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A multi-component, multi-level programme (MoviMusi)
Description: The MoviMusi program will be designed and implemented in each city by the 12 ECEC centres in the intervention group. In addition, the intervention programme will aim to address the main barriers and facilitators identified during the first year (baseline assessment) in relation to movement and music curricular practices. The programme will have three axes:~(1) Training. Educators and families will actively participate in a series of seminars and training workshops on the promotion of PA as a healthy behaviour and the use of music as a didactic resource to strengthen holistic education both inside and outside ECEC. (2) Participation. Each ECEC institution will be supported as they design a movement and music programme to offer children better opportunities to learn about the body, its possibilities of action, and musical skills.(3) Implementation. The specific actions of the MoviMusi Programme will be put into practice in each ECEC institution.
Study NCT06201611 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nebivolol+ Standard care arm
Description: This arm will receive tablet Nebivolol 2.5 mg OD uptitrated at 2 weeks to 5 mg and at 4 weeks if well tolerated to 10 mg/day which the participant will continue upto week 24
Study NCT06201611 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epalrestat + Alpha Lipoic Acid +Standard care
Description: This arm will receive tablet Epalrestat -150mg OD+ cap Alpha Lipoic Acid 600mg OD for 24 weeks.
Study NCT06201611 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard care alone
Description: Patients in this arm will receive standard care as judged by their treating physicians which is generally pain modifying treatment.
Study NCT06352567 — intervention group
Intervention type: OTHER
Intervention: European Organization for Research and Treatment of Cancer-Chemotherapy Induced Peripheral Neuropathy (EORTC-CIPN20) questionnaire
Description: It consists of a total of 20 items each is scored from 1: not at all to 4: very much in a 4-point Likert scale. Individuals are requested to fill out by considering their last week. Sensory, motor, and autonomic subscales are reported within its constructs. A total of 9, 8, and 3 items are referred to as sensory, motor, and autonomic disturbances, respectively
Study NCT06631001 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Abdominal Massage
Description: Abdominal massage will be administered twice a day for 15 minutes over three days. This intervention aims to evaluate its effects on defecation frequency, gastric residual volume, and abdominal distension.
Study NCT04846946 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hey, Friend
Description: Intervention in development. However, we will use intervention mapping and the designing for dissemination approach, informed by self-reported qualitative data, to develop the Hey, Friend modules. The mHealth intervention will include three modules that include multiple sub-topics (e.g., What is HIV?; How do I protect myself from HIV?; What is PrEP?, etc.), deliver culturally appropriate counseling content in community settings, juvenile court system, clinics, and schools; will include Motivational Interviewing components that are effective in evoking behavior change while being acceptable to adolescents and parents, and will include ongoing support through a text reminder to maximize the likelihood of initiating HIV prevention through testing and PrEP.
Study NCT06628492 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: stainless steel printed surgical guide
Description: the patient will wear the stainless steel surgical guide for the insertion of one implant
Study NCT06628492 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: resin printed surgical guide
Description: the patient will wear the resin surgical guide for insertion of adjacent another implant implant
Study NCT04706013 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyridoxal Phosphate
Description: Oral tablets 50 mg
Study NCT04716946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Patients will receive durvalumab 1500mg durvalumab via IV infusion over 1 hour, once every 4 weeks (Q4W) for up to a maximum of 6 months (up to 6 doses/cycles) unless there is unacceptable toxicity, withdrawal of consent, or another discontinuation criterion is met.
Study NCT04716946 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy
Description: Radiation therapy will be performed with external beam ionizing radiation in accordance with institutional standard practice. 3D conformal radiation therapy (3D-CRT), intensity-modulated radiation therapy (IMRT) or volumetric arc therapy (VMAT) will be used at the discretion of the treating radiation oncologist.
Study NCT05060510 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Take home saliva kit
Description: Saliva kits will be made available at schools for pick up to support symptomatic testing using PCR for students, staff and family members.
Study NCT05248620 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin Clavulanic 500/125mg or placebo
Description: Prophylactic antibiotic treatment